Thalidomide for Patients with β-Thalassemia: A Multicenter Experience

OBJECTIVE: This study focused on the efficacy and safety of thalidomide for patients with β-thalassemia in a multicenter trial. METHODS: Patients with non-transfusion-dependent thalassemia (NTDT) or transfusion-dependent thalassemia (TDT), who were unable to pursue conventional therapy with transfus...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kun, Wu, Yi, Zhou, Yali, Long, Binbin, Lu, Qian, Zhou, Tianhong, Wang, Li, Geng, Zhili, Yin, Xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202343/
https://www.ncbi.nlm.nih.gov/pubmed/32395210
http://dx.doi.org/10.4084/MJHID.2020.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202343/
https://www.ncbi.nlm.nih.gov/pubmed/32395210
http://dx.doi.org/10.4084/MJHID.2020.021

Ejemplares similares